Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation Ablation

Sponsor
Military Institute of Medicine, Poland (Other)
Overall Status
Completed
CT.gov ID
NCT02476227
Collaborator
(none)
90
1
2
34.1
2.6

Study Details

Study Description

Brief Summary

Catheter ablation in the treatment of atrial fibrillation (i.e. pulmonary vein isolation) is now the most effective method of prevention of arrhythmia recurrence. Use of 3D electroanatomical system is now a golden standard.

Background hypothesis is that automatic algorithm collecting ablation points during pulmonary vein isolation (with certain catheter stability time, range of motion, and catheter-tissue contact force) prevents forming the gaps in the ablation line, thus preventing pulmonary vein reconnection and AF recurrence. The aim of the trial will be 1:1 comparison of the two methods of pulmonary vein isolation: with manual vs. automatic collection of ablation points using CARTO system and contact force catheter.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ablation using CARTO system
N/A

Detailed Description

Atrial fibrillation (AF) is the most common sustained supraventricular arrhythmia. It increases the risk of hospitalization and all-cause mortality. AF causes about 5-fold increase in the risk of stroke and 3-fold increase in the risk of heart failure.

Catheter ablation in the treatment of AF (i.e. pulmonary vein isolation) is now the most effective method of prevention of arrhythmia recurrence, especially in paroxysmal AF. Still, efficacy of one procedure in a 1-year follow-up is between 20 and 80%, depending on demographic and clinical factors (concomitant diseases), and on the form of the arrhythmia (paroxysmal-persistent), it also depends on the method of ablation used and the experience of the centre. In a big European registry including over 1,300 patients antiarrhythmic drugs-free efficacy of catheter ablation in AF in 1-year follow-up was about 40%. Major finding in patients with AF recurrence after catheter ablation is pulmonary vein reconnection, so decreasing the risk of pulmonary vein reconnections seems crucial to diminish the risk of AF recurrence. Several novel technologies have been proposed lately to improve efficacy of AF ablation, their real importance needs validation in a clinical trial.

Current standard is radiofrequency (RF) ablation with manual collection of ablation points (by operator or assistant). Automatic algorithm collect ablation points with additional criteria: catheter stability time, range of motion, and catheter-tissue contact force. The operator can see more precisely where the RF current has been applied and where are the gaps in the line.

Background hypothesis is that automatic algorithm collecting ablation points (with certain catheter stability time, range of motion, and catheter-tissue contact force) prevents forming the gaps in the ablation line, thus preventing pulmonary vein reconnection and AF recurrence.

The aim of the trial will be 1:1 comparison of the two methods of pulmonary vein isolation:

with manual vs. automatic collection of ablation points using CARTO system and contact force catheter.

Study Design

Study Type:
Interventional
Actual Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Comparison of Operator-guided and Automatic Algorithm-guided Atrial Fibrillation Ablation. Randomized Open-labeled Study
Study Start Date :
Apr 1, 2015
Actual Primary Completion Date :
Jan 1, 2017
Actual Study Completion Date :
Feb 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Visitag group

Ablation using CARTO system. Visitag module: automated algorithm to collect RF ablation points using Visitag module. Criteria of ablation point: catheter stability range of motion ≤2.5mm, catheter stability time >15sec, contact force >5g over >50% of time. Optimal contact force suggested: 10-40g.

Procedure: Ablation using CARTO system
automated algorithm (Visitag)-based vs. manual collection of RF ablation points during AF ablation
Other Names:
  • RF ablation (CARTO system)
  • Pulmonary vein isolation (CARTO system)
  • Active Comparator: Control group

    Ablation using CARTO system. Manual collection of RF ablation points by operator or by assistant. Optimal contact force suggested: 10-40g.

    Procedure: Ablation using CARTO system
    automated algorithm (Visitag)-based vs. manual collection of RF ablation points during AF ablation
    Other Names:
  • RF ablation (CARTO system)
  • Pulmonary vein isolation (CARTO system)
  • Outcome Measures

    Primary Outcome Measures

    1. AF recurrence [1-year follow-up after index procedure]

      Number of AF recurrence after single catheter ablation during 12 months of follow-up.

    Secondary Outcome Measures

    1. Arrhythmia-free survival [Time to arrhythmia recurrence, follow-up 3-18 months after index procedure]

      Comparison of arrhythmia-free survival curves during the whole follow-up (even if extending over 1 year)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • patients with symptomatic atrial fibrillation qualified to catheter ablation according to current standards
    Exclusion Criteria:
    • lack of informed consent

    • two previous pulmonary vein isolations

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Military Institute of Medicine Warsaw Poland 04-141

    Sponsors and Collaborators

    • Military Institute of Medicine, Poland

    Investigators

    • Principal Investigator: Marek Kiliszek, MD, PhD, Military Institute of Medicine

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Marek Kiliszek, Principal Investigator, Military Institute of Medicine, Poland
    ClinicalTrials.gov Identifier:
    NCT02476227
    Other Study ID Numbers:
    • 1
    First Posted:
    Jun 19, 2015
    Last Update Posted:
    Mar 29, 2018
    Last Verified:
    Mar 1, 2018
    Keywords provided by Marek Kiliszek, Principal Investigator, Military Institute of Medicine, Poland
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 29, 2018